Why Farbe Firma is the Top Manufacturer of Phenytoin Sodium Injection
- Maulik Sudani
- 4 days ago
- 7 min read
Last Updated: June 14, 2026
TL;DR: Phenytoin Sodium Injection — a sterile, clear, essentially colourless aqueous solution of phenytoin sodium, a hydantoin anticonvulsant and class Ib antiarrhythmic, supplied commonly as a 250 mg/5 mL ampoule or vial (50 mg/mL) for slow intravenous injection — is a frontline hospital and emergency agent for the control of status epilepticus, for the prevention and treatment of seizures during and after neurosurgery, and for emergency seizure management. Phenytoin sodium is formulated as a highly alkaline, non-aqueous-co-solvent solution (with propylene glycol and ethanol) at a tightly controlled high pH that keeps the poorly soluble drug in solution, it has a narrow therapeutic index and a real risk of precipitation and infusion-site and cardiovascular reactions if administered incorrectly, so each ampoule must deliver an exact, sterile, particulate-free dose. Its safety and shelf life depend on a precise stability-indicating assay, a tightly controlled pH and co-solvent system, a controlled impurity and degradation profile, accurate fill-volume control, low particulate and endotoxin, a validated sterilisation route and verified container-closure integrity. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Phenytoin Sodium Injection at our Gujarat, India facility and supplies it to hospital pharmacy, neurology, emergency and critical-care services, tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Hydantoin anticonvulsant and class Ib antiarrhythmic — Phenytoin Sodium Injection is used for the emergency control of status epilepticus, for the prevention and treatment of seizures during and after neurosurgery, and for acute seizure management, delivered by slow intravenous injection at a controlled rate.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, controlled high-pH solution compounding and ampoule filling lines, dedicated control of the stability-indicating assay, the co-solvent system, solution pH, the impurity profile, fill volume, particulate and endotoxin for a narrow-therapeutic-index parenteral, with container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, sterilisation and container-closure data, drug master files and CEP-style documentation for registrations including ministry-of-health, hospital-formulary and institutional tenders.
End-to-end CDMO services: Sterile-solution contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tamper-evident tender-ready ampoule packaging and import/export coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Phenytoin Sodium Injection Demands a Premium Manufacturer
Phenytoin Sodium Injection holds a critical, frontline place in neurology, emergency medicine and critical care across every market. It is the intravenous hydantoin anticonvulsant that clinicians reach for when seizures must be brought under control quickly and reliably — in status epilepticus, where a prompt, accurately delivered dose can be life-saving; in the prevention and treatment of seizures during and after neurosurgery; and in acute emergency seizure management. Given as a slow intravenous injection at a controlled rate, phenytoin sodium suppresses the abnormal electrical activity that drives seizures, and the same molecule has a recognised class Ib antiarrhythmic action. In each of these settings the dose delivered from each ampoule must be exact, sterile, particulate-free and reliably the same from unit to unit, because phenytoin has a narrow therapeutic index and, in an emergency, there is no margin for an inaccurate or contaminated dose.
That clinical reality places real demands on the manufacturer. Phenytoin sodium is a poorly water-soluble drug, so it is presented as a highly alkaline, non-aqueous-co-solvent solution — formulated with propylene glycol and ethanol and adjusted to a tightly controlled high pH — that keeps the drug fully in solution; that solution must remain clear and free of precipitate and particulates throughout shelf life. The assay must be exact; the pH and the co-solvent composition must be controlled tightly because they govern solubility and precipitation risk; the impurity and degradation profile must stay within tight limits; the deliverable volume must be accurate so each ampoule gives the labelled dose; the solution must be free of visible and sub-visible particulates and low in endotoxin; and it must be sealed in a container whose closure integrity holds across shelf life. Choosing a Phenytoin Sodium Injection manufacturer that treats the stability-indicating assay, the high-pH and co-solvent control, fill-volume accuracy, the validated sterilisation route, particulate and endotoxin control and container-closure integrity as core engineering disciplines is what protects the patient at the point of care.
What Sets a World-Class Phenytoin Sodium Injection Manufacturer Apart
A world-class manufacturer of Phenytoin Sodium Injection invests in three areas that weaker suppliers underfund: a precise, stability-indicating assay of phenytoin with the tight related-substance and degradation-product control by HPLC that a narrow-therapeutic-index parenteral demands, a robust, validated aseptic solution-fill process built around the highly alkaline propylene-glycol/ethanol co-solvent system — with terminal moist-heat sterilisation where the formulation and container permit it, otherwise sterile filtration and aseptic filling — that protects the assay, the pH and the clarity of the solution, and tender-ready dossier support for a hospital-formulary emergency product procured through pharmacy and ministry-of-health channels. It starts with the active — pharmacopoeial-grade phenytoin sodium sourced from qualified, audited API makers, with full assay, related-substance and impurity profiling and certificates of analysis verified by the receiving laboratory before the material enters production.
Compounding and filling then have to defend both the assay and the dose. The bulk solution is compounded in water-for-injection with the propylene glycol and ethanol co-solvents and adjusted to the controlled high pH that keeps phenytoin sodium stable and fully in solution, sterile-filtered through 0.22 µm membrane, and filled into ampoules under ISO Class 5 conditions, with the validated sterilisation route — terminal moist-heat where qualified, otherwise full aseptic processing — locked in the master batch record. Filled ampoules are 100 % inspected for fill, seal, clarity, precipitate and particulate defects; in-process and release testing confirm phenytoin assay by validated HPLC, the related-substance profile, solution pH, co-solvent content where specified, deliverable volume, visible and sub-visible particulate matter, and endotoxin is held well within limits so the injection is safe for slow intravenous administration. Because solubility and precipitation risk hinge on pH and the co-solvent system, these parameters are controlled and verified with particular rigour.
Quality Systems Behind Every Phenytoin Sodium Injection
Every Farbe Firma Phenytoin Sodium Injection batch is released only after a full stack of quality checks: stability-indicating HPLC assay of phenytoin against pharmacopoeial reference standards, control of related substances and degradation products by HPLC, solution pH, deliverable (fill) volume, clarity and colour of the solution with checks for precipitate, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, validated sterilisation and depyrogenation equipment, validated ampoule-filling lines with 100 % inspection, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Because phenytoin has a narrow therapeutic index and the assay, the high pH, the co-solvent composition, clarity and particulate burden drive both efficacy and safety, we treat the stability-indicating HPLC assay, the solution pH, the co-solvent control, the deliverable volume and the related-substance profile as critical quality attributes and trend them across batches, not merely as one-off release tests. Stability is tracked under both long-term (25 °C / 60 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions, with ICH Q1B photostability challenge.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Phenytoin Sodium Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables, including a broad small-volume parenteral portfolio across neurology, critical-care, cardiovascular and supportive-care categories. For Phenytoin Sodium Injection specifically, we supply the 250 mg/5 mL (50 mg/mL) single-dose ampoule of sterile solution under WHO-GMP conditions, with country-specific strengths, fill configurations, tamper-evident packs and pack counts available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the stability-indicating-assay, pH, co-solvent, sterilisation and container-closure data package — ready to hand for registration and tender qualification.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, sterilisation and container-closure reports, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics to the destination market. When a buyer needs Phenytoin Sodium Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, validation reports, artwork, line slot and shipment plan delivered as a single coordinated package.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, stability-indicating assay development, related-substance and degradation control, the high-pH and propylene-glycol/ethanol co-solvent design, solubility and precipitation control, the choice between terminal sterilisation and aseptic filling, fill-volume and deliverable-dose control, particulate and endotoxin control, container-closure integrity and shelf-life choices in real detail. For a narrow-therapeutic-index emergency anticonvulsant where assay accuracy, pH, the co-solvent system and particulate control directly govern both effect and safety, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Phenytoin Sodium Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Phenytoin Sodium Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, controlled high-pH solution compounding and ampoule filling lines, validated sterilisation, qualified water-for-injection systems, 100 % inspection and continuous environmental monitoring.
Which strengths and pack sizes of Phenytoin Sodium Injection do you supply?
Our standard presentation is the 250 mg/5 mL (50 mg/mL) single-dose ampoule of sterile phenytoin sodium solution, for slow intravenous injection. Custom strengths, fill configurations, ampoule or vial formats, tamper-evident counts per pack and country-specific artwork are available under contract manufacturing agreements.
Why is pH and co-solvent control so important for Phenytoin Sodium Injection?
Phenytoin sodium is poorly water-soluble, so it is held in solution by a highly alkaline, propylene-glycol/ethanol co-solvent system at a tightly controlled high pH. If the pH or co-solvent composition drifts, the drug can precipitate. Farbe Firma controls and verifies pH, co-solvent content where specified, assay, clarity and particulate matter so each ampoule delivers a clear, precipitate-free, labelled dose for safe slow intravenous administration.
Can Farbe Firma support country-specific registrations for Phenytoin Sodium Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substances method-validation data, sterilisation and container-closure reports, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. We support registrations and tender qualification in 30+ countries across Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
What is the minimum order quantity for Phenytoin Sodium Injection contract manufacturing?
MOQs vary by strength, ampoule size, sterilisation route, label complexity and dossier requirements. For our small-volume parenteral presentations we accommodate hospital-scale and full national-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments